1. Report on the WFH Global Survey, 2005 (www.wfh.org) [WFH – World Federation of Hemophilia – Всемирная федерация гемофилии].
2. Kasper CK. Hereditary plasma clotting disorders and their
management. Treatment of hemophilia, N.4. WFH, 2004.
3. Kumar P, Clark M et al. Clinical Medicine, 6th ed. Elsevier
Saunders, 2005; 472-3.
4. Lyon M.F. X-chromosome inactivation and human genetic
disease. Acta Paediatr. Suppl, 2002; 91 (439): 107–12.
5. Новицкий В.В., Гольдберг Е.Д. и др. Патофизиология.
Томск, 2001; 432–7.
6. Ключевые моменты в лечении гемофилии: препараты
и терапия. Факты и цифры. WFH, 1997: 1.
7. Guidelines for the management of hemophilia. WFH, 2005.
8. Гемофилия: информация для медицинского персонала.
Совместное издание ВОЗ и ВФГ, программа по генетике
человека, 1996.
9. Manucci PM. Desmopressin (DDAVP) in the treatment of
bleeding disorders: first 20 years. Treatment of hemophilia,
WFH, 1998; 11.
10. HB Bolton-Maggs P. The Rare coagulation disorders. Treatment
of hemophilia, WFH *, 2006; 39.
11. Gilbert MS. Sceletal and muscular complications of hemophilia.
Treatment of hemophilia. WFH, 1997; 6.
12. Rodruguez-Merchan EC. Articular bleeding (hemarthrosis)
in hemophilia. Treatment of hemophilia. WFH, 2003; 23.
13. Pathogenesis, early diagnosis, and prophylaxis for chronic
hemophilic synovitis. Clin Orthop 1997; 343: 6–11.
14. Chuah MKL, Collen D, Vandendriessche T. Preclinical and
clinical gene therapy for hemophilia. Haemophilia 2004; 10
(s4): 119–25.
15. Key issues in hemophilia treatment: part 1. Facts and figues.
WFH, 1998; 1.
16. Lloyd S. The preparation of single donor cryoprecipitate.
Facts and figures. WHF, 2004; 2.
17. Kasper CK, Brooker M. Registry of clotting factor concentrates,
7th ed. Facts and figures. WFH, 2006.
18. Dietrich SL. The treatment of hemophilia bleeding with limited
resources. Treatment of hemophilia. WFH, 2004; 1.
19. Silva M, Luck JV jr, Llinas A. Chronic hemophilic synovitis: the
role of radiosynovectomy. Treatment of hemophilia. WFH, 2004; 33.
20. Beeton K, Alltree J, Cornwall J. Rehabilitation of muscle dysfunction
in hemophilia. Treatment of hemophilia. WFH, 2001; 24.
21. Scully C, Dios PD, Giangrande P, Lee C. Oral care for people
with hemophilia or a hereditary bleeding tendency. Treatment of hemophilia. WFH, 2002; 27.
22. Kelley RC. An introduction to gene therapy. Treatment of
hemophilia. WFH, 2000; 17.
23. Lillicrap D, Thompson AR. Gene therapy for the hemophilias.
Treatment of hemophilia. WFH, 2004; 18.
24. Giangrande P. Acquired hemophilia. Treatment of hemophilia.
WFH, 2005; 38.
25. Kasper CK. Diagnosis and management of inhibitors to factors
VIII and IX. Treatment of hemophilia. WFH, 2004; 34.
26. O'Mahony B. Plasma-derived and biotech products: what is
the future of haemophilia therapy? WFH, 1999.
27. Evatt B. Creutzfeldt–Jakob disease and hemophilia: assessment
of risk. Treatment of hemophilia. WFH, 2004; 15.